Investigational drugs opaganib and RHB-107 (upamostat) demonstrate distinct synergistic effect when combined individually with remdesivir, significantly improving...
Phase III Study
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of...
